Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
Accepting patients
ON-TRK
PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
- Tyrosine Kinase (TK) Inhibitor